164 related articles for article (PubMed ID: 12114879)
1. A review of the efficacy of bone scanning in prostate and breast cancer.
O'Sullivan JM; Cook GJ
Q J Nucl Med; 2002 Jun; 46(2):152-9. PubMed ID: 12114879
[TBL] [Abstract][Full Text] [Related]
2. Position of nuclear medicine modalities in the diagnostic work-up of breast cancer.
Buscombe JR; Holloway B; Roche N; Bombardieri E
Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):109-18. PubMed ID: 15243412
[TBL] [Abstract][Full Text] [Related]
3. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
Langsteger W; Heinisch M; Fogelman I
Semin Nucl Med; 2006 Jan; 36(1):73-92. PubMed ID: 16356797
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography and bone metastases.
Fogelman I; Cook G; Israel O; Van der Wall H
Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry.
Hillner BE; Siegel BA; Hanna L; Duan F; Quinn B; Shields AF
J Nucl Med; 2015 Feb; 56(2):222-8. PubMed ID: 25593113
[TBL] [Abstract][Full Text] [Related]
6. Bone metastases: assessment of therapeutic response through radiological and nuclear medicine imaging modalities.
Vassiliou V; Andreopoulos D; Frangos S; Tselis N; Giannopoulou E; Lutz S
Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):632-45. PubMed ID: 21530193
[TBL] [Abstract][Full Text] [Related]
7. Detection of bone metastases in breast cancer by positron emission tomography.
Schirrmeister H
Radiol Clin North Am; 2007 Jul; 45(4):669-76, vi. PubMed ID: 17706531
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer: role of SPECT and PET in imaging bone metastases.
Beheshti M; Langsteger W; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):396-407. PubMed ID: 19801219
[TBL] [Abstract][Full Text] [Related]
10. Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers: An Overview.
Azad GK; Taylor B; Rubello D; Colletti PM; Goh V; Cook GJ
Clin Nucl Med; 2016 Jan; 41(1):e44-50. PubMed ID: 26402127
[TBL] [Abstract][Full Text] [Related]
11. Review of imaging techniques for evaluating morphological and functional responses to the treatment of bone metastases in prostate and breast cancer.
Orcajo-Rincon J; Muñoz-Langa J; Sepúlveda-Sánchez JM; Fernández-Pérez GC; Martínez M; Noriega-Álvarez E; Sanz-Viedma S; Vilanova JC; Luna A
Clin Transl Oncol; 2022 Jul; 24(7):1290-1310. PubMed ID: 35152355
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice.
Lawrentschuk N; Davis ID; Bolton DM; Scott AM
Int J Urol; 2007 Feb; 14(2):89-95. PubMed ID: 17302562
[TBL] [Abstract][Full Text] [Related]
13. Skeletal scintigraphy in breast cancer management.
Bares R
Q J Nucl Med; 1998 Mar; 42(1):43-8. PubMed ID: 9646644
[TBL] [Abstract][Full Text] [Related]
14. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
[TBL] [Abstract][Full Text] [Related]
15. Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning.
Ahmadzadehfar H; Essler M; Rahbar K; Afshar-Oromieh A
PET Clin; 2018 Oct; 13(4):491-503. PubMed ID: 30219184
[TBL] [Abstract][Full Text] [Related]
16. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
17. [Skeletal scintigraphy in the care of breast cancer . Long-term follow-up over 8 years].
Anger K; Möller T; Zeimantz E
Strahlentherapie; 1983 Dec; 159(12):745-50. PubMed ID: 6665812
[TBL] [Abstract][Full Text] [Related]
18. [Imaging bone metastases in breast cancer].
Withofs N; Collignon J; Hustinx R
Rev Med Liege; 2011; 66(5-6):291-8. PubMed ID: 21826965
[TBL] [Abstract][Full Text] [Related]
19. [Cancer of the prostate: value of bone scintigraphy. Point of view].
Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
[TBL] [Abstract][Full Text] [Related]
20. Nuclear medicine studies of the prostate, testes, and bladder.
Jana S; Blaufox MD
Semin Nucl Med; 2006 Jan; 36(1):51-72. PubMed ID: 16356796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
